TrialAmerican journal of hematology2010
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma.
Patrick B Johnston et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
90 papers cite itlatest 60 shown
this paperpooled ittrialcites it